CytomX Therapeutics, Inc. Gains 40.78%
Fri, Jan 06, 2023 at 07:02 PM
CytomX Therapeutics, Inc. (CTMX:NASDAQ) rocketted at $2.52, a gain of 40.8%. On Fri, Jan 06, 2023, CTMX:NASDAQ hit a New 2-Week High of $2.52. The stock appeared on our News Catalysts scanner on Fri, Jan 06, 2023 at 03:59 PM in the 'PATNERSHIP' category. From Fri, Dec 23, 2022, the stock recorded 87.50% Up Days and 55.56% Green Days
About CytomX Therapeutics, Inc. (CTMX:NASDAQ)
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.
Top 10 Gainers:
- Moolec Science SA (MLEC:NASDAQ), 258.47%
- Swvl Holdings Corp (SWVL:NASDAQ), 115.36%
- Spruce Biosciences Inc. (SPRB:NASDAQ), 93.6%
- MultiMetaVerse Holdings Ltd Ord (MMV:NASDAQ), 82%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 80.19%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 77.78%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 53.72%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 45.24%
- Oxbridge Re Holdings Limited (OXBR:NASDAQ), 43.51%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 40.78%